explore -WSS

explore

author：knowledge 2025-09-06 03:33:36 - browse：5735

Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

“You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Undocumented workers face uncertainty as immigration law takes effect in Florida

focus

WSS

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Dog Aging Project founders on what lies ahead after losing funding

The biotech scorecard for Q3: 15 stock

AstraZeneca lung cancer study comes in below expectations

Skip the lead apron during X

Beware reading your test results before your doctor does

Wikipedia

explore

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Trump demands the U.S. pay no more for drugs than other countries … again

FDA sets aggressive timeline for overhauling inspection procedures

Medicare proposal to cover medical devices draws a mixed reaction

Fatty liver disease was alleviated by Lilly’s ‘triple

Sports medicine is finally prioritizing gender equality

Dog Aging Project founders on what lies ahead after losing funding

As demand for Covid shots wanes, Moderna seeks its next success

Future doctors need a strong humanities education

focus

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Maisha Meds is a PBM, but don't call it that

Medicare bonuses could stop drug shortages under Senate plan

Printout prescription drug information shouldn’t go digital

AstraZeneca lung cancer study comes in below expectations

Beware reading your test results before your doctor does

hotspot

Wikipedia

focus

hotspot